Evergraf 0.25Mg Tablet
Evergraf 0.25Mg Tablet is included in a class of medications called kinase inhibitors that treats cancer by stopping cancer cells from reproducing and cutting off blood supply to the cancer cells. Evergraf 0.25Mg Tablet decreases the action of the immune system. This may result in increased risk of developing infection or certain types of cancer such as lymphoma, skin cancer, etc.
Evergraf 0.25Mg Tablet (Afinitor) is used for the treatment of advanced renal cell carcinoma (after all other treatments have failed), a certain type of advanced breast cancer(after unsuccessful treatment using other medications), a certain type of cancer of the pancreas that has spread too much and cannot be treated with surgery, kidney tumours in people with tuberous sclerosis complex (TSC; a genetic condition that causes tumours to grow in multiple organs) and subependymal giant cell astrocytoma (SEGA; a type of brain tumour) in adults and children 1 year of age and older who have TSC. Evergraf 0.25Mg Tablet (Zortress) is used with other medications to prevent transplant rejection in certain adults who have received kidney transplants. Evergraf 0.25Mg Tablet may increase the risk of developing a blood clot that may cause you to lose the transplanted kidney and of kidney damage, especially when Evergraf 0.25Mg Tablet is used along with certain doses of cyclosporine (also used to suppress the immune system).
Some side effects may include infection with symptoms like sore throat, chills, fever, frequent and painful urination, or unusual itching, night sweats, unexplained weight loss, unusual growths or lumps and swollen lymph nodes.
Information given here is based on the salt and content of the medicine. Effect and uses of medicine may vary from person to person. It is advicable to consult a Oncologist before using this medicine.
Is It safe with alcohol?
Are there any pregnancy warnings?
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Are there any breast-feeding warnings?
Is it safe to drive while on this medicine?
Does this affect kidney function?
Does this affect liver function?
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.